|
Academic/Biomedical Research
News & Jobs
|
|
|
|
|
|
|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Company Profiles
Research Store
Research Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
11/2/2011 9:46:23 AM
BETHLEHEM, Pa., Nov. 1, 2011 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq:OSUR) today issued a statement in support of updated recommendations issued by the American Academy of Pediatrics ("AAP") on HIV screening for adolescents. These recommendations, which advocate regular, routine HIV screening for all adolescents 16 to 18 years of age in healthcare settings when the prevalence of HIV in the patient population is more than 0.1%, were included in a policy statement entitled "Adolescents and HIV Infection: The Pediatrician's Role in Promoting Routine Testing." The statement was issued yesterday by the AAP and published in PEDIATRICS, Volume 128, Number 5, November 2011.
|
|
|
|
|
|
|
|
|
|
|